본문 바로가기
KERD
논문KCI 등재

連翹 n-BuOH 분획물의 아토피 피부염 억제 효과

The Effects of Forsythiae Fructus n-BuOH Fraction on Atopic Dermatitis

김윤희|한재경|이진화
대한한방소아과학회 (The Association of Pediatrics of Korean Medicine)|2016.08|대한한방소아과학회지 (The Journal of Pediatrics of Korean Medicine)|제30권 제3호|pp. 1-30

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

Atopic dermatitisNC/Nga miceDNCBRBL-2H3 mast cellIL-31連翹 (Forsythiae Fructus)n-BuOH fraction
주제분류한의학

초록

Objectives Previous studies have found out that Forsythiae Fructus (FF) extracts have anti-atopic activities by in vitro experiment. In order to understand more about FF extracts’ benefit, we subdivided FF extracts depending on systematic fractionation method by using Methylene chloride (MC), Ethyl acetate (EtOAc), n-BuOH and n-hexane (n-Hx). This study is designed to examine the effect of FF fractions on the PMA- ionomycin-induced activation of RBL-2H3 mast cell lines in vitro and on the DNCB-induced activation of NC/Nga mice in vivo. Methods For this study, we examined IL-4, IL-13 production by ELISA analysis, IL-4, IL-13, IL-31, IL-31RA and TNF-α mRNA expression by real-time PCR and manifestations of AP-1 and MAPKs transcription factors by western blotting in vitro. Through in vitro experiment, we selected FF n-BuOH fraction that seems the best effective in atopic dermatitis then induced it on NC/Nga mice by DNCB. We measured mice’s WBC, eosinophil and neutrophil in heart blood, IL-4, IL-5, IFN-γ in the spleenocyte culture supernatant, the absolute cell numbers of CD4+, CD8+, B220+CD23+, CD3+CD69+ and Gr-1+CD11b+ in the PBMCs, ALN and dorsal skin, IL-5, IL-13, IL-31, IL-31RA in the dorsal skin by real-time PCR and the distribution of immune cells by H&E on dorsal skin and ANL and toluidine blue staining on dorsal skin. Results FF n-BuOH fraction suppressed IL-4, IL-13 production and mRNA expression of IL-4, IL-13, IL-31, IL-31RA and TNF-α. Results from the western blot analysis showed that FF n-BuOH fraction reduced the activation of the mast cell specific transduction factors involved in AP-1 by suppressing JNK and ERK phosphorylation. In the gross, atopic dermatitis induced by DNCB in NC/Nga mice were improved by oral administration of FF n-BuOH fraction. Oral FF n-BuOH fraction also decreased the level of IgE in mice’s serum and the level of IL-4 and IL-5 in the spleenocyte culture supernatant, cell numbers of CD8+, B220+CD23+ in the PBMCs, CD4+ in the ALN and CD4+, Gr-1+CD11b+ in the dorsal skin and suppressed mRNA expression of IL-5, IL-13, IL-31, IL-31RA in the dorsal skin. Histological examination showed that infiltration levels of immune cells in atopic dermatitis induced NC/Nga mice were improved by FF n-BuOH fraction. Conclusions FF n-BuOH fraction can reduce pruritus by suppressing IL-31, IL-31RA secretion and modulate molecular mediators and immune cells associated with atopic dermatitis induced in NC/Nga mice which may have played a significant role in recovering atopic dermatitis symptoms.

Abstract

Objectives Previous studies have found out that Forsythiae Fructus (FF) extracts have anti-atopic activities by in vitro experiment. In order to understand more about FF extracts’ benefit, we subdivided FF extracts depending on systematic fractionation method by using Methylene chloride (MC), Ethyl acetate (EtOAc), n-BuOH and n-hexane (n-Hx). This study is designed to examine the effect of FF fractions on the PMA- ionomycin-induced activation of RBL-2H3 mast cell lines in vitro and on the DNCB-induced activation of NC/Nga mice in vivo. Methods For this study, we examined IL-4, IL-13 production by ELISA analysis, IL-4, IL-13, IL-31, IL-31RA and TNF-α mRNA expression by real-time PCR and manifestations of AP-1 and MAPKs transcription factors by western blotting in vitro. Through in vitro experiment, we selected FF n-BuOH fraction that seems the best effective in atopic dermatitis then induced it on NC/Nga mice by DNCB. We measured mice’s WBC, eosinophil and neutrophil in heart blood, IL-4, IL-5, IFN-γ in the spleenocyte culture supernatant, the absolute cell numbers of CD4+, CD8+, B220+CD23+, CD3+CD69+ and Gr-1+CD11b+ in the PBMCs, ALN and dorsal skin, IL-5, IL-13, IL-31, IL-31RA in the dorsal skin by real-time PCR and the distribution of immune cells by H&E on dorsal skin and ANL and toluidine blue staining on dorsal skin. Results FF n-BuOH fraction suppressed IL-4, IL-13 production and mRNA expression of IL-4, IL-13, IL-31, IL-31RA and TNF-α. Results from the western blot analysis showed that FF n-BuOH fraction reduced the activation of the mast cell specific transduction factors involved in AP-1 by suppressing JNK and ERK phosphorylation. In the gross, atopic dermatitis induced by DNCB in NC/Nga mice were improved by oral administration of FF n-BuOH fraction. Oral FF n-BuOH fraction also decreased the level of IgE in mice’s serum and the level of IL-4 and IL-5 in the spleenocyte culture supernatant, cell numbers of CD8+, B220+CD23+ in the PBMCs, CD4+ in the ALN and CD4+, Gr-1+CD11b+ in the dorsal skin and suppressed mRNA expression of IL-5, IL-13, IL-31, IL-31RA in the dorsal skin. Histological examination showed that infiltration levels of immune cells in atopic dermatitis induced NC/Nga mice were improved by FF n-BuOH fraction. Conclusions FF n-BuOH fraction can reduce pruritus by suppressing IL-31, IL-31RA secretion and modulate molecular mediators and immune cells associated with atopic dermatitis induced in NC/Nga mice which may have played a significant role in recovering atopic dermatitis symptoms.

참고문헌 (65)

  1. Ahn HS, "Hongchangui pediatrics", pp.1142~ (2010), Miraen
  2. 박용민, "아토피피부염 병태생리에 대한 최신 지견", Allergy Asthma & Respiratory Diseases, 16(3), pp.189~196 (2006), 대한 소아알레르기 호흡기학회
  3. Mudde GC, "Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE", Immunol, 69(3), pp.335~341 (1990)
  4. Markus G, "A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis", Immunol, 19(8), pp.359~361 (1998)
  5. Reijsena FC, "Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis", J Allergy Clin Immunol, 90(2), pp.184~193 (1992)
  6. Foster PS, "Interleukins -4, -5, and -13; emerging therapeutic targets in allergic disease", Pharmacol Ther, 94(3), pp.253~624 (2002)
  7. Matsubara M, "Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells", Biochem Pharmacol, 67(7), pp.1315~1326 (2004)
  8. Hanifin JM, "Diagnostic features of atopic dermatitis", Acta Derm Venereol, 92, pp.44~47 (1980)
  9. 윤주희, "아토피 증상 영유아기 자녀를 양육하는 부모의 어려움과 요구", 생태유아교육연구, 12(1), pp.113~137 (2013), 한국생태유아교육학회
  10. Harri A, "IL-31: A new link between T cells and pruritus in atopic skin inflammation", J Allergy Clin Immunol, 177(2), pp.411~417 (2006)
  11. Song Kim, "IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis", Annals of Dermatology, 23(4), pp.468~473 (2011), 대한피부과학회
  12. Ulrike R, "Correlation of IL-31 serum levels with severity of atopic dermatitis", J Allergy Clin Immunol, 122(2), pp.421~423 (2006)
  13. Grimstad Q, "Anti interleukin 31 antibodies ameliorate scratching behaviour in NC", Nga mice; a model of atopic dermatitis, 2009, pp.18(1), 35~43
  14. Ju YS, "Ungok herbology", pp.494~497 (2013), Woosuk Press
  15. Herbology Association of Korea's Colleges of Oriental Medicine, "Textbook of herbology", pp.199~ (1991), Younglimsa
  16. 이진화, "비만세포에서 連翹 추출물의 Th2 사이토카인 발현 및 신호전달 기전 억제효과", 대한한방소아과학회지, 28(3), pp.31~46 (2014), 대한한방소아과학회[DOI]
  17. 남정범, "連翹 에탄올 추출물의 대식세포의 염증성 사이토카인 합성과 신호전달에 대한 조절", 대한본초학회지, 27(1), pp.59~64 (2012), 대한본초학회
  18. 김성윤, "연교 추출물의 Microglia에서 LPS에 의해 유도되는 염증매개물질 생성 억제 효과", 대한본초학회지, 23(3), pp.93~102 (2008), 대한본초학회
  19. 이정민, "연교(Forsythia viridissima Lindl.) 추출물이 고콜레스테롤 식이 흰쥐 간조직의 항산화계와 지질과산화에 미치는 영향", Journal of Nutrition and Health, 36(10), pp.990~996 (2003), 한국영양학회
  20. 정유정, "충울자 EtOAc 분획의 항알러지 및 항염증 효과", 약 학 회 지, 58(5), pp.294~299 (2014), 대한약학회
  21. Yang CH, "Effect of Zizyphi Fructus extract on the biological activity of Gingival Fibroblast", J Korean Periodontol, 24(1), pp.144~154 (1994)
  22. 이은주, "생강 분획의 gingerols 분석 및 초임계 추출물의 항산화 효과", 한국식품과학회지, 43(4), pp.469~474 (2011), 한국식품과학회
  23. 정복미, "함초 분획물의 in vitro에서의 암세포 성장억제 및 Quinone Reductase 활성 유도 효과", 한국식품영양과학회지, 37(2), pp.148~153 (2008), 한국식품영양과학회
  24. 김정희, "아토피피부염의 최신지견", Allergy Asthma & Respiratory Diseases, 14(1), pp.12~23 (2004), 대한 소아알레르기 호흡기학회
  25. 오재원, "1995년과 2000년의 학동기와 2003년 학동전기 소아에서의 아토피피부염의 역학적 변화에 관한 전국적인 연구", Allergy Asthma & Respiratory Diseases, 13(4), pp.227~237 (2003), 대한 소아알레르기 호흡기학회
  26. Greer FR, "Effect of early nutritional interventions on the development of atopic disease in infants and children; the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas", Pediatr, 111, pp.608~616 (2008)
  27. Vander H, "Risk of developing asthma in young children with atopic eczema; a systemic review", J Allegy Clin Immunol, 120, pp.565~569 (2007)
  28. 이지현, "아토피피부염학회 보고서: 한국 아토피피부염의 치료지침", 대한피부과학회지, 44(8), pp.907~913 (2006), 대한피부과학회
  29. Katayama I, "Japanese guideline for atopic dermatitis", Allergol Int, 60, pp.205~220 (2011)
  30. Schacke H, "Mechanisms involved in the side effects of glucocorticoids", Pharmacol Ther, 96, pp.23~43 (2002)
  31. Dowell SF, "Severe varicella associated with steroid use", Pediatr, 92, pp.223~228 (1993)
  32. 김수찬, "피부외용제에 의한 부작용 사례 연구", 대한피부과학회지, 41(9), pp.1129~1135 (2003), 대한피부과학회
  33. 진현우, "아토피피부염 환자의 대체의학 이용 실태에 관한 연구", 대한피부과학회지, 43(7), pp.903~911 (2005), 대한피부과학회
  34. Kim SH, "The use of oriental and complementary alternative medicine in children with atopic dermatitis", Maste, pp.2007
  35. 고덕재, "Clinical Assessment of Efficacy, Safety and Usefulness of Traditional Herbal Medicine (THM) on Atopic Dermatitis", 대한한방소아과학회지, 20(2), pp.129~137 (2006), 대한한방소아과학회
  36. Schulz F, "A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema", J Allergy Clin Immunol, 120, pp.1097~1102 (2007)
  37. Zhang Q, "Structures and biological functions of IL-31 and IL-31 receptors", Cytokine Growth Factor Rev, 19(2008), pp.347~356 (2008)
  38. Cornelissen C, "Signaling by IL-31 and functional consequences", Eur J Cell Biol, 91(2012), pp.552~566 (2011)
  39. Ha NL, "Recent research on treatments of atopic dermatitis in Japan", Diet Kampo Med, 26(1), pp.16~35 (2012)
  40. 민들레, "아토피 피부염 외용제에 관련된 국내 임상 및 실험 논문 고찰", 대한한방소아과학회지, 27(1), pp.36~49 (2013), 대한한방소아과학회
  41. 윤지연, "加味淸心蓮子湯이 NC", Nga mice의 아토피樣 피부염에 미치는 영향, 2007, pp.21(1), 87~116[DOI]
  42. 고민정, "黃連解毒湯이 아토피 피부염에 미치는 영향에 대한 임상적 연구", 대한한방소아과학회지, 26(4), pp.51~60 (2012), 대한한방소아과학회[DOI]
  43. 박젬마, "DNCB로 유발된 생쥐의 아토피 피부염에 대한 지실 (枳實)의 효능", 대한한방소아과학회지, 29(1), pp.27~43 (2015), 대한한방소아과학회
  44. 여의주, "玄蔘이 NC", Nga mice에서 유발된 피부염에 미치는 영향, 2007, pp.21(2), 13~34[DOI]
  45. Liebmann C, "Regulation of MAP kinase activity by peptide receptor signalling pathway; paradigms of multiplicity", Cell Signal, 13, pp.777~785 (2001)
  46. Whitmarsh AJ, "Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways", J Mol Med, 74, pp.589~607 (1996)
  47. Lewin I, "Regulation of AP-1 expression and activity in antigen-stimulated mast cells; the role played by protein kinase C and the possible involvement of Fos interacting protein", Blood, 82, pp.3745~3751 (1993)
  48. 윤용갑, "아토피 피부염 치료제 개발에 활용할 수 있는 마우스 모델에 대한 고찰", 대한한의학 방제학회지, 15(1), pp.145~162 (2007), 대한한의학방제학회
  49. Venkayya R, "The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells", Am J Respir Cell Mol Biol, 26, pp.202~208 (2002)
  50. Kim HM, "Immune and allergic", pp.168~222 (2008), Shinil Books
  51. Humbert M, "High-affinity IgE receptor (Fcepsiolon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma", Am J Respir Crit Care Med, 153, pp.1931~1937 (1996)
  52. Toru H, "Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking; enhanced IL-13 production by IL-4-primed human mast cells", J Allergy Clin Immunol, 102(3), pp.491~502 (1998)
  53. Kim JW, "Atopic dermatitis at allergic and immunological aspects", J Korean Dermatol Assoc, 41(6), pp.687~689 (2003)
  54. Abbas Abul K, "Cellular and Molecular Immunology", pp.304~315 (2007), Saunders
  55. Mehrotra PT, "Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes", J Immunol, 151(5), pp.2444~2452 (1993)
  56. Zdolsek HA, "Expression of the T-cell markers CD3, CD4 and CD8 in healthy and atopic children during the first 18 months of life", Arch Allergy Immunol, 119, pp.6~12 (1999)
  57. Kim SJ, "Immunology", pp.150~206 (1994), Koryo medicine
  58. Rich Robert R, "Clinical immunology", pp.13~ (2001), Mosby
  59. Dorshkind K, "Regulatory cells and cytokines involved in primary B lymphocyte production", Adv Exp Med Biol, 323, pp.119~123 (1992)
  60. Askenasea Philip W, "A new paradigm of T cell allergy; requirement for the B-1 cell subset", Int Arch Allergy Immunol, 118, pp.145~149 (1999)
  61. Bronte V, "Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+", Gr-1+ cells, 1998, pp.161(10), 5313~5320
  62. Angulo I, "Nitric oxide-producing CD11b (+)Ly- 6G (Gr-1) (+)CD31 (ER-MP12) (+) cells in the spleen of cyclophosphamide- treated mice: implications for T-cell responses in immuno-suppressed mice", Blood, 95(1), pp.212~220 (2000)
  63. Park EH, "Effect of Hyunggaeyunkyotangbalhyobang (HYBH) on atopic dermatitis in NC", Nga mice model, 2011, pp.19(2), 65~83
  64. 김윤희, "아토피樣 피부염 NC", Nga 생쥐에서 消風導赤湯加味와 아토피크림, 紫雲膏 및 消風導赤湯加味의 병용투여가 피부염에 미치는 영향, 2010, pp.24(1), 9~35[DOI]
  65. 이윤실, "白鮮皮 추출물이 DNCB로 유발된 NC", Nga 생쥐의 아토피 피부염에 미치는 영향, 2014, pp.28(4), 1~29[DOI]

관련 논문AI추천

白鮮皮 추출물이 DNCB로 유발된 NC/Nga 생쥐의 아토피 피부염에 미치는 영향김윤희, 이윤실, 한재경대한한방소아과학회 · 대한한방소아과학회지2014 · 제28권 제4호杏仁 분획물이 Th2 cytokine 발현과 NC/Nga mouse의 아토피 피부염에 미치는 영향강기연, 김윤희, 한재경대한한방소아과학회 · 대한한방소아과학회지2016 · 제30권 제4호加味羌活散이 집먼지 진드기 추출물로 유도된 NC/Nga mouse의 아토피 피부염에 미치는 영향김윤희, 한재경대한한방소아과학회 · 대한한방소아과학회지2008 · 제22권 제1호아토피樣 피부염 NC/Nga생쥐에서 加減消毒飮과 아토피크림-紫雲膏의 병용투여가 피부염에 미치는 영향김윤희, 송현지, 한재경대한한방소아과학회 · 대한한방소아과학회지2009 · 제23권 제2호아토피 피부염 동물 모델에서 아토피 크림과 紫雲膏의 병용도포가 피부염에 미치는 영향김윤희, 여의주, 한재경대한한방소아과학회 · 대한한방소아과학회지2009 · 제23권 제1호황련 추출물의 아토피피부염 유발 생쥐에서 피부손상 완화 효과김기봉, 안상현, 정아람, 정한솔한의병리학회 · 동의생리병리학회지2019 · 제33권 제2호

이 간행물의 다른 논문 (8건)

알레르기성 비염환아들의 양도락 특성에 관한 연구이진용, 안주현pp. 31-41Helicobacter pylori 감염과 관련된 철결핍성 빈혈 환아 증례보고전보람, 김장현, 민상연pp. 42-51국소한약외용제의 알레르기성 비염 치료 효과에 대한 문헌 고찰방미란, 민상연, 김장현pp. 52-60식간 (食癎)으로 진단된 영아기 환아 1례에 대한 증례 보고이은주, 장규태, 이보람, 이지홍pp. 61-68관동화 및 관동화 가미방이 흰쥐의 간독성 및 신독성에 미치는 영향김은진, 김장현, 민상연pp. 69-77
원문 보기